Robust, significant levels of Ipa-specific ocular IgA were induced across all groups with IpaB and IpaC-specific IgA levels showing a decreasing trend with increasing amounts of LPS present in the vaccine formulations ( Fig. 2C, II and III ).
← all excerpts
Development of the <i>Shigella flexneri</i> 2a, 3a, 6, and <i>S. sonnei</i> artificial Invaplex (Invaplex<sub>AR</sub>) vaccines.
1
—
—